Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
DRUG-THERAPY FOR ULCERATIVE-COLITIS DURING PREGNANCY
Autore:
MODIGLIANI R;
Indirizzi:
HOP ST LOUIS,1 AVE CLAUDE VELLEFAUX F-75475 PARIS 10 FRANCE
Titolo Testata:
European journal of gastroenterology & hepatology
fascicolo: 9, volume: 9, anno: 1997,
pagine: 854 - 857
SICI:
0954-691X(1997)9:9<854:DFUDP>2.0.ZU;2-B
Fonte:
ISI
Lingua:
ENG
Soggetto:
INFLAMMATORY BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; AZATHIOPRINE; CYCLOSPORINE; SAFETY; WOMEN; 6-MERCAPTOPURINE; MESALAZINE; EXPOSURE; IBD;
Keywords:
ULCERATIVE COLITIS; PREGNANCY; SULFASALAZINE; MESALAZINE; OLSALAZINE; CORTICOSTEROIDS; AZATHIOPRINE AND 6-MERCAPTOPURINE; CYCLOSPORINE; METHOTREXATE;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
27
Recensione:
Indirizzi per estratti:
Citazione:
R. Modigliani, "DRUG-THERAPY FOR ULCERATIVE-COLITIS DURING PREGNANCY", European journal of gastroenterology & hepatology, 9(9), 1997, pp. 854-857

Abstract

Women with ulcerative colitis (UC) are usually young and thus likely to undergo pregnancy. They should be advised to conceive when the disease is quiescent. Steroids and salicylates may be used normally duringpregnancy, possibly without exceeding a dose of 2 g/day for mesalazine. Azathioprine can be maintained if its indication is clear cut. Cyclosporin seems to be without additional risk in the pregnant woman, itsuse being limited to acute steroid-refractory disease, as an alternative to surgery.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/09/20 alle ore 18:42:33